Results 241 to 250 of about 1,875,792 (320)

LncRNA AC040169.1 is regulated by m6A modification and suppresses ferroptosis via SLC7A11 to promote ovarian cancer progression. [PDF]

J Ovarian Res
Yang H, Dong Y, Li R, Zhu L, Yang L.
europepmc   +1 more source

Unveiling the role of m6A modification in esophageal cancer: a new frontier in tumor innate interferon immunity. [PDF]

Cancer Cell Int
Zuo X, Liu G, Guo J, Wang Y.
europepmc   +1 more source

METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation. [PDF]

Oncol Lett
Liu L, Sheng S, Zheng X, Huang S, Wang L, Shu D, Tang L, He Q.   +7 more
europepmc   +1 more source

ADSC-derived exosomes inhibit myofibroblast transdifferentiation and attenuate airway stenosis via METTL3-mediated m6A modification of TLR2. [PDF]

Am J Transl Res
Zhang G, Zheng T, Guo W, Zhuang X.
europepmc   +1 more source

Emerging links between mA and misregulated mRNA methylation in cancer [PDF]

core   +1 more source

m6A modification in R-loop homeostasis: a potential target for cancer therapeutics. [PDF]

NAR Cancer
Vu MA, Spagnuolo M, Chen CL.
europepmc   +1 more source

Clinofibrate Disrupts the SNORA80B/YTHDC1-Driven M6A Modification to Suppress Cholesterol Metabolism and Cisplatin Resistance in ESCC. [PDF]

Adv Sci (Weinh)
Yuan H, Ge G, Liu L, Hu S, Tian M, Nie Y, Zhao Z, Song Y.   +7 more
europepmc   +1 more source

TNF-α-driven m6A modification disrupts the immunoregulatory function of MSCs by regulating HDAC5-dependent super-enhancers. [PDF]

Cell Death Dis
Zhang W, Lin J, Zhou Y, Wu C, Li Q, Chen J, Zeng Y, Xiao Z, Shen H, Wu Y, Su Z, Yu W, Xie Z.   +12 more
europepmc   +1 more source

Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA. [PDF]

Int J Biol Sci
Wu X, Gao H, Zhuang Q, Li F, Feng X, Shao N, Zhang W, Zhang Y, Zhang X.   +8 more
europepmc   +1 more source